MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report

Cellular Oncology

Volumn 40, Issue 1, 2017, Pages 97-103

  Caivano, Antonella ^a   La Rocca, Francesco ^a   Simeon, Vittorio ^a   Girasole, Marco ^b   Dinarelli, Simone ^b   Laurenzana, Ilaria ^a   De Stradis, Angelo ^c   De Luca, Luciana ^a   Trino, Stefania ^a   Traficante, Antonio ^a   D’Arena, Giovanni ^a   Mansueto, Giovanna ^a   Villani, Oreste ^a   Pietrantuono, Giuseppe ^a   Laurenti, Luca ^d   Del Vecchio, Luigi ^e   Musto, Pellegrino ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b CNR   (Italy)

^c INSTITUTE FOR SUSTAINABLE PLANT PROTECTION   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acute myeloid leukemia; Chronic lymphocytic leukemia; Extracellular vesicles; miR155; Myelodysplastic syndrome; Waldenstr m s macroglobulinemia

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN; TUMOR MARKER;

ACUTE MYELOID LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ATOMIC FORCE MICROSCOPY; BIC GENE; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSE LARGE B CELL LYMPHOMA; EXOSOME; FEMALE; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NON INVASIVE PROCEDURE; ONCOGENE; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSMISSION ELECTRON MICROSCOPY; WALDENSTROEM MACROGLOBULINEMIA; AREA UNDER THE CURVE; BLOOD; GENETICS; HEMATOLOGIC DISEASE; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS, TUMOR; EXTRACELLULAR VESICLES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MICRORNAS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84991809180     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-016-0300-x     Document Type: Article

References (40)

1. S. Lin, R. I. Gregory, MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15, 321–333 (2015)
2. J. Hayes, P. P. Peruzzi, S. Lawler, MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20, 460–469 (2014)
3. I. Fkih, M’hamed, M. Privat, F. Ponelle, F. Penault-Llorca, a. Kenani, Y.J. Bignon, identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol 38, 433–442 (2015)
4. V. Taucher, H. Mangge, J. Haybaeck, R. N. A. Non-coding, In pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol 39, 295–318 (2016)
5. M. Shahjahani, J. Mohammadiasl, F. Noroozi, M. Seghatoleslami, S. Shahrabi, F. Saba, N. Saki, Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. Cell Oncol 38, 93–109 (2015)
6. B. Ortiz-Quintero, Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif 49, 281–303 (2016)
7. M. Vitiello, A. Tuccoli, L. Poliseno, Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol 38, 17–28 (2015)
8. D. L. Zhaolei Cui, Circulating miRNAs: potential biomarkers for diagnosis and prognosis prediction of hematological malignancies. J Leuk 2, 1–15 (2014)
9. M. Yáñez-Mó, P.R.M. Siljander, Z. Andreu, A. Bedina Zavec, F.E. Borràs, E.I. Buzás, K. Buzas, E. Casal, F. Cappello, J. Carvalho, E. Colás, A. Cordeiro-da Silva, S. Fais, J.M. Falcon-Perez, I.M. Ghobrial, B. Giebel, M. Gimona, M. Graner, I. Gursel, M. Gursel, N.H.H. Heegaard, A. Hendrix, P. Kierulf, K. Kokubun, M. Kosanovic, V. Kralj-Iglic, E. M. Krämer-Albers, S. Laitinen, C. Lässer, T. Lener, E. Ligeti, A. Linē, G. Lipps, A. Llorente, J. Lötvall, M. Manček-Keber, A. Marcilla, M. Mittelbrunn, I. Nazarenko, E.N.M. Nolte-Hoen‘t, T.A. Nyman, L. O’Driscoll, M. Olivan, C. Oliveira, É. Pállinger, H.A. del Portillo, J. Reventós, M. Rigau, E. Rohde, M. Sammar, F. Sánchez-Madrid, N. Santarém, K. Schallmoser, M. Stampe Ostenfeld, W. Stoorvogel, R. Stukelj, S.G. Van der Grein, M.H. Vasconcelos, M.H.M. Wauben, O. De Wever, Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4, 319–325 (2015)
10. S. Raimondo, C. Corrado, L. Raimondi, G. De Leo, R. Alessandro, Role of extracellular vesicles in hematological malignancies. Biomed Res Int 2015, 1–9 (2015)
11. L. M. Desrochers, M. A. Antonyak, R. A. Cerione, Extracellular vesicles: satellites of information transfer in cancer and stem cell biology. Dev Cell 37, 301–309 (2016)
12. L. De Luca, S. Trino, I. Laurenzana, V. Simeon, G. Calice, S. Raimondo, M. Podestà, M. Santodirocco, L. Di Mauro, F. La Rocca, A. Caivano, A. Morano, F. Frassoni, D. Cilloni, L. Del Vecchio, P. Musto, MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation. Oncotarget 7, 6676–6692 (2015)
13. I. Tatischeff, Cell-derived extracellular vesicles open new perspectives for cancer research. Cancer Res Front 1, 208–224 (2015)
14. A. Caivano, I. Laurenzana, L. De Luca, F. La Rocca, V. Simeon, S. Trino, F. D’Auria, A. Traficante, M. Maietti, T. Izzo, G. D’Arena, G. Mansueto, G. Pietrantuono, L. Laurenti, P. Musto, L. Del Vecchio, High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol 36, 9739–3752 (2015)
15. I. Faraoni, F. R. Antonetti, J. Cardone, E. Bonmassar, miR-155 gene: a typical multifunctional microRNA. Biochem. Biophys. Acta 1792, 497–505 (2009)
16. R. Mashima, Physiological roles of miR-155. Immunology 145, 323–333 (2015)
17. T. S. Elton, H. Selemon, S. M. Elton, N. L. Parinandi, Regulation of the MIR155 host gene in physiological and pathological processes. Gene 532, 1–12 (2013)
18. R. W. Georgantas, R. Hildreth, S. Morisot, J. Alder, C. G. Liu, S. Heimfeld, G. A. Calin, C. M. Croce, C. I. Civin, CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 104, 2750–2755 (2007)
19. C.-H. Yeh, R. Moles, C. Nicot, Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer 15, 37–53 (2016)
20. M. Girasole, S. Dinarelli, G. Boumis, Structural, morphological and nanomechanical characterisation of intermediate states in the ageing of erythrocytes. J Mol Recognit 25, 285–291 (2012)
21. M. Colombo, G. Raposo, C. Théry, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30, 255–289 (2014)
22. D. Zocco, P. Ferruzzi, F. Cappello, W. P. Kuo, Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front. Oncologia 4, 267–274 (2014)
23. A. Gallamini, M. Hutchings, S. Ramadan, Clinical presentation and staging of Hodgkin lymphoma. Semin Hematol 53, 148–154 (2016)
24. Y.-Y. Yeh, H. G. Ozer, A. M. Lehman, K. Maddocks, L. Yu, A. J. Johnson, J. C. Byrd, Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood 125, 3297–3305 (2015)
25. A. Ferrajoli, T. D. Shanafelt, C. Ivan, M. Shimizu, K. G. Rabe, N. Nouraee, M. Ikuo, A. K. Ghosh, S. Lerner, L. Z. Rassenti, L. Xiao, J. Hu, J. M. Reuben, S. Calin, M. J. You, J. T. Manning, W. G. Wierda, Z. Estrov, S. O’Brien, T. J. Kipps, M. J. Keating, N. E. Kay, G. A. Calin, Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood 122, 1891–1899 (2013)
26. S. A. Parikh, T. D. Shanafelt, Prognostic factors and risk stratification in chronic lymphocytic leukemia. Semin Oncol 43, 233–240 (2016)
27. A. Sacco, Y. Zhang, P. Maiso, S. Manier, G. Rossi, S. P. Treon, I. M. Ghobrial, A. M. Roccaro, Aberrations in Waldenström macroglobulinemia. Clin Lymphoma Myeloma Leuk 13, 205–210 (2013)
28. A. M. Roccaro, A. Sacco, C. Chen, J. Runnels, X. Leleu, F. Azab, A. K. Azab, X. Jia, H. T. Ngo, M. R. Melhem, N. Burwick, L. Varticovski, C. D. Novina, B. J. Rollins, K. C. Anderson, I. M. Ghobrial, microRNA aberrations in Waldenström macroglobulinemia. Blood 113, 4391–4402 (2009)
29. P. Morel, A. Duhamel, P. Gobbi, M. A. Dimopoulos, M. V. Dhodapkar, J. McCoy, J. Crowley, E. M. Ocio, R. G. Sanz, S. P. Treon, V. Leblond, R. A. Kyle, B. Barlogie, G. Merlini, International prognostic scoring system for Waldenström macroglobulinemia. Blood 113, 4163–4170 (2009)
30. N. I. Hornick, J. Huan, B. Doron, N. A. Goloviznina, J. Lapidus, B. H. Chang, P. Kurre, Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Report 5, 11295–11307 (2015)
31. H. J. M. de Jonge, P. J. M. Valk, E. S. J. M. de Bont, J. J. Schuringa, G. Ossenkoppele, E. Vellenga, G. Huls, Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD. Haematologica 96, 1310–1317 (2011)
32. I. De Kouchkovsky, M. Abdul-Hay, Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 6, e441 (2016)
33. D. W. Lee, M. Futami, M. Carroll, Y. Feng, Z. Wang, M. Fernandez, Z. Whichard, Y. Chen, S. Kornblau, E. J. Shpall, C. E. Bueso-Ramos, S. J. Corey, Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 31, 4085–4094 (2012)
34. A. Pons, B. Nomdedeu, A. Navarro, A. Gaya, B. Gel, T. Diaz, S. Valera, M. Rozman, M. Belkaid, E. Montserrat, M. Monzo, Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 50, 1854–1859 (2009)
35. P. L. Greenberg, N. S. Young, N. Gattermann, Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454–2465 (2012)
36. D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz, M. M. Le Beau, C. D. Bloomfield, M. Cazzola, J. W. Vardiman, Reclassifying myelodysplastic syndromes: what’s where in the new WHO and why. Blood 127, 2391–2405 (2016)
37. N. Gangat, M. M. Patnaik, A. Tefferi, Myelodysplastic syndromes: contemporary review and how we treat. Am J Hematol 91, 76–89 (2015)
38. P. Krzeminski, M.E. Sarasquete, I. Misiewicz-Krzeminska, R. Corral, L.A. Corchete, A.A. Martín, R. Garcia-Sanz, J.F. San-Miguel, N. C. Gutierrez, Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma. Biochim Biophys Acta 1849, 353–366 (2015)
39. M. Feng, X. Luo, C. Gu, J. Fei, Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. J Drug Target 23, 59–66 (2014)
40. M. Lionetti, M. Biasiolo, L. Agnelli, K. Todoerti, L. Mosca, S. Fabris, G. Sales, G. L. Deliliers, S. Bicciato, L. Lombardi, S. Bortoluzzi, A. Neri, Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 114, e20 (2009)